For the Inventor, By the Inventor

Enter assignee name

Salt Lake City, UT, United States of America

Watson Pharmaceuticals, Inc.

USPTO Granted Patents = 27

CIPO Patents = 4

EPO Patents = 4

Trademarks = 42

Forward Citations = 609

Loading Chart...

Loading Chart...

39 inventors (with patents filed for the assignee):

Avinash Nangia (5 out of 24 patents)

Charles D Ebert (5 out of 44 patents)

Srinivasan Venkateshwaran (4 out of 38 patents)

4. Unchalee Kositprapa (4 out of 15 patents)

5. John R Cardinal (4 out of 6 patents)

6. Robert I Goldfarb (4 out of 5 patents)

7. Danyi Quan (4 out of 10 patents)

8. Thomas Ho (3 out of 4 patents)

9. Nilesh H Parikh (3 out of 3 patents)

10. Steven W Sanders (2 out of 11 patents)

11. Theresa Rosario-Jansen (2 out of 3 patents)

12. Norman A Mazer (2 out of 4 patents)

13. David Chung Hsia (2 out of 2 patents)

14. Domingo Yap Tan (2 out of 2 patents)

15. Fredric B Weihmuller (2 out of 2 patents)

27 patents: Sort by Forward Citations

1. 9259388 - Method for treating overactive bladders and a device for storage and administration of topical oxybutynin compositions (2016-02-16),

2. 9198858 - Methods of treating bacterial vaginosis with aqueous-based metronidazole gel formulations (2015-12-01),

3. 8597683 - Modified release tranexamic acid formulation (2013-12-03),

4. 8470368 - Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative (2013-06-25),

5. 8309125 - Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative (2012-11-13),

6. 8309104 - Oral controlled release formulation for sedative and hypnotic agents (2012-11-13),

7. 8084058 - Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative (2011-12-27),

8. 7959946 - Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative (2011-06-14),

9. 7785627 - Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative (2010-08-31),

10. 7338667 - Pharmaceutical formulation (2008-03-04),

11. 7186706 - Administration of non-oral androgenic steroids to women (2007-03-06),

12. 7179483 - Compositions and methods for transdermal oxybutynin therapy (2007-02-20),

13. 6866865 - Dosage forms and methods for oral delivery of progesterone (2005-03-15),

14. 6743441 - Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy (2004-06-01),

15. 6730318 - Transdermal delivery devices containing polydiorganosiloxane polymers to regulate adhesive properties (2004-05-04),

Watson Pharmaceuticals, Inc. is a global pharmaceutical company focused on the development, manufacturing, and marketing of generic, branded, and over-the-counter pharmaceutical products. Watson Pharmaceuticals is now part of Teva Pharmaceutical Industries Ltd., a leading global pharmaceutical company that specializes in the development, production, and distribution of generic and specialty medicines. Visit their website for more information and to explore their wide range of pharmaceutical products.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

27 Patents

#61 in Salt Lake City, UT

#141 in Utah

#12,007 in US

#23,290 in the World

Salt Lake City, UT, United States of America

Watson Pharmaceuticals, Inc.

Forward Citations = 609

39 inventors:

Avinash Nangia (5 out of 24 patents)

Charles D Ebert (5 out of 44 patents)

Srinivasan Venkateshwaran (4 out of 38 patents)

4. Unchalee Kositprapa (4 out of 15 patents)

5. John R Cardinal (4 out of 6 patents)

Please report any incorrect information to support@idiyas.com

Loading…